N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004357:Drug Synergism; D006834:Hydrazines / Q000494:pharmacology; D066298:In Vitro Techniques; D007737:Kynurenine / Q000378:metabolism*; D051379:Mice; D008930:Mitochondria, Liver / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology*; D014191:Tranylcypromine / Q000494:pharmacology
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D011437:Propylamines; D007737:Kynurenine; D014191:Tranylcypromine; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D008995:Monoamine Oxidase